Results 141 to 150 of about 6,770,889 (217)

USP38: an important regulatory factor in tumor malignant progression. [PDF]

Front Immunol
Li J, Zhong J, Ye J, Xiang Y, Yi Q, Zhu G, Deng S, Wang X.   +7 more
europepmc   +1 more source

Deciphering the mechanistic roles of ADARs in cancer pathogenesis, tumor immune evasion, and drug resistance. [PDF]

Front Immunol
Wang X, Yin F, He Y, Qiao Y, Yan Y, Ma J.   +5 more
europepmc   +1 more source

KDM5 demethylases suppress R-loop-mediated 'viral mimicry' and DNA damage in breast cancer cells. [PDF]

Elife
Lau L, Henderson K, Turkoz A, Linker S, Schlessinger D, Townsley B, Egan B, Ragunathan S, Rollins R, Bi X, Chen ZJ, Brodsky O, Restaino C, Gururajan M, Jensen-Pergakes K, Mälarstig A, Kermi C, Moore P, Classon M.   +18 more
europepmc   +1 more source

ADAR1 editing is necessary for only a small subset of cytosolic dsRNAs to evade MDA5-mediated autoimmunity. [PDF]

Nat Genet
Sun T, Li Q, Geisinger JM, Hu SB, Fan B, Su S, Tsui W, Guo H, Ma J, Li JB.   +9 more
europepmc   +1 more source

A systematic evaluation of the therapeutic potential of endogenous-ADAR editors in cancer prevention and treatment. [PDF]

NAR Cancer
Merdler-Rabinowicz R, Dadush A, Patiyal S, Rajagopal PS, Daya GN, Ben-Aroya S, Schäffer AA, Eisenberg E, Ruppin E, Levanon EY.   +9 more
europepmc   +1 more source

Tripartite motif 47 promotes the development of thyroid carcinoma through ADAR ubiquitination. [PDF]

Mol Med
Liu H, Hu X, Li T, Wang Y, Fu X.
europepmc   +1 more source

The <i>CTDP1</i> Founder Variant in CCFDN: Insights into Pathogenesis, Phenotypic Spectrum and Therapeutic Approaches. [PDF]

Int J Mol Sci
Sabau IM, Chera A, Ungureanu VG, Cretu Stancu M, Chirita-Emandi A, Wood M, Puiu M, Bucur O.   +7 more
europepmc   +1 more source

In-depth analysis of the RNA editing landscape in intracranial aneurysms and its potential role in alternative splicing. [PDF]

Comput Struct Biotechnol J
Wang Y, Li Q, Wang P, Xu T, Zhao X, Ye M.   +5 more
europepmc   +1 more source

Gene editing for collagen disorders: current advances and future perspectives. [PDF]

Gene Ther
Kocsy K, Wilkinson H, Felix-Ilemhenbhio F, Bax B, Van Agtmael T, Azzouz M, Majid A.   +6 more
europepmc   +1 more source

Systematic identification and characterization of high efficiency Cas9 guide RNAs for therapeutic targeting of ADAR. [PDF]

PLoS One
Gowen BG, Melton K, Leong WI, Khekare P, McCawley S, Chan J, Boivin P, Jani V, Cantor AJ, Tambe A, Haak-Frendscho M, Janatpour MJ, Wei SC.   +12 more
europepmc   +1 more source